NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Home » pressreleases » Gnosis increases its production capacity with a new fermenter

Human Nutrition and Health

Press
Release

Gnosis increases its production capacity with a new fermenter

Gnosis is glad to present R-1004, the new fermentation line that started operation at Pisticci manufacturing plant in the beginning of November. It is entirely dedicated to the production of vitaMK7.

This 120 m3 fermenter, which Gnosis hope will satisfy the growing number of customers of our vitamin K2 as MK7, will increase the fermentative capacity of the plant to 350 m3.

VitaMK7 is today one of the top ingredients provided by Gnosis, firmly in line with the current market demand for products with a clean label and a purity profile. It is produced naturally from the patented biofermentation process of the Bacillus subtilis natto within Gnosis’ reliable manufacturing plant of Pisticci Operations, which is FDA and AIFA approved, with cGMP, HACCP, ISO 22000, Kosher, Halal certifications.

The plant achieves manufacturing excellence through the application of good science and minimising the environmental footprint.

Gnosis works transparently and offers the opportunity to control every step of the vitaMK7 products’ manufacturing process to its customers and partners. It enables them to understand how this pure, stable, safe, high quality vitamin K2 as MK7 can be produced and why it is also suitable for people with dietary restrictions.

To learn more visit our dedicated website www.vitaMK7.com and see the videos published about Pisticci plant and vitaMK7 supply chain at Gnosis videos Pisticci/vitaMK7.

Contact Human Nutrition and Health

Human Nutrition and Health